Principal Financial Group’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-119,214
| Closed | -$1.18M | – | 2250 |
|
|
2025
Q2 | $1.18M | Sell |
119,214
-794
| -0.7% | -$7.77K | ﹤0.01% | 1862 |
|
|
2025
Q1 | $1.13M | Buy |
120,008
+24,047
| +25% | +$253K | ﹤0.01% | 1836 |
|
|
2024
Q4 | $879K | Buy |
+95,961
| New | +$706K | ﹤0.01% | 1889 |
|
|
2024
Q2 | – | Sell |
-11,440
| Closed | -$67.2K | – | 2370 |
|
|
2024
Q1 | $67.2K | Sell |
11,440
-1,423
| -11% | -$8.45K | ﹤0.01% | 2317 |
|
|
2023
Q4 | $101K | Sell |
12,863
-548
| -4% | -$3.8K | ﹤0.01% | 2272 |
|
|
2023
Q3 | $98K | Sell |
13,411
-217,349
| -94% | -$1.81M | ﹤0.01% | 2284 |
|
|
2023
Q2 | $2.41M | Sell |
230,760
-11,592
| -5% | -$112K | ﹤0.01% | 1735 |
|
|
2023
Q1 | $2.51M | Sell |
242,352
-3,025
| -1% | -$38.7K | ﹤0.01% | 1725 |
|
|
2022
Q4 | $3.38M | Sell |
245,377
-7,169
| -3% | -$99.7K | ﹤0.01% | 1657 |
|
|
2022
Q3 | $5.17M | Sell |
252,546
-13,813
| -5% | -$303K | ﹤0.01% | 1482 |
|
|
2022
Q2 | $5.15M | Sell |
266,359
-15,940
| -6% | -$326K | ﹤0.01% | 1550 |
|
|
2022
Q1 | $6.08M | Sell |
282,299
-13,774
| -5% | -$313K | ﹤0.01% | 1602 |
|
|
2021
Q4 | $8.17M | Sell |
296,073
-7,779
| -3% | -$215K | ﹤0.01% | 1497 |
|
|
2021
Q3 | $7.88M | Sell |
303,852
-1,964
| -0.6% | -$52.5K | 0.01% | 1514 |
|
|
2021
Q2 | $8.3M | Buy |
305,816
+26,698
| +10% | +$652K | 0.01% | 1508 |
|
|
2021
Q1 | $6.53M | Buy |
279,118
+1,253
| +0.5% | +$25.3K | ﹤0.01% | 1571 |
|
|
2020
Q4 | $4.26M | Sell |
277,865
-26,675
| -9% | -$339K | ﹤0.01% | 1622 |
|
|
2020
Q3 | $3.67M | Buy |
304,540
+4,915
| +2% | +$46.7K | ﹤0.01% | 1573 |
|
|
2020
Q2 | $3.05M | Buy |
299,625
+13,707
| +5% | +$141K | ﹤0.01% | 1597 |
|
|
2020
Q1 | $2.98M | Sell |
285,918
-13,385
| -4% | -$168K | ﹤0.01% | 1473 |
|
|
2019
Q4 | $4.79M | Sell |
299,303
-9,109
| -3% | -$139K | ﹤0.01% | 1544 |
|
|
2019
Q3 | $5.68M | Sell |
308,412
-2,194
| -0.7% | -$42.9K | 0.01% | 1466 |
|
|
2019
Q2 | $6.12M | Sell |
310,606
-266
| -0.1% | -$5.42K | 0.01% | 1457 |
|
|
2019
Q1 | $7.11M | Sell |
310,872
-2,997
| -1% | -$65.1K | 0.01% | 1419 |
|
|
2018
Q4 | $6.32M | Sell |
313,869
-7,318
| -2% | -$151K | 0.01% | 1410 |
|
|
2018
Q3 | $6.98M | Buy |
321,187
+12,725
| +4% | +$283K | 0.01% | 1493 |
|
|
2018
Q2 | $6.86M | Buy |
308,462
+10,294
| +3% | +$210K | 0.01% | 1498 |
|
|
2018
Q1 | $5.14M | Buy |
298,168
+7,871
| +3% | +$131K | ﹤0.01% | 1549 |
|
|
2017
Q4 | $4.83M | Sell |
290,297
-3,536
| -1% | -$60.3K | ﹤0.01% | 1582 |
|
|
2017
Q3 | $5.02M | Buy |
293,833
+15,637
| +6% | +$263K | ﹤0.01% | 1555 |
|
|
2017
Q2 | $4.51M | Buy |
278,196
+24,722
| +10% | +$391K | ﹤0.01% | 1578 |
|
|
2017
Q1 | $4.4M | Buy |
253,474
+11,709
| +5% | +$196K | 0.01% | 1574 |
|
|
2016
Q4 | $4.08M | Buy |
241,765
+33,599
| +16% | +$560K | 0.01% | 1583 |
|
|
2016
Q3 | $3.65M | Buy |
208,166
+21,242
| +11% | +$345K | ﹤0.01% | 1566 |
|
|
2016
Q2 | $2.69M | Buy |
186,924
+4,689
| +3% | +$58.6K | ﹤0.01% | 1607 |
|
|
2016
Q1 | $2.24M | Buy |
182,235
+7,916
| +5% | +$87.5K | ﹤0.01% | 1601 |
|
|
2015
Q4 | $2.12M | Buy |
174,319
+8,640
| +5% | +$106K | ﹤0.01% | 1627 |
|
|
2015
Q3 | $2.19M | Buy |
165,679
+8,145
| +5% | +$123K | ﹤0.01% | 1625 |
|
|
2015
Q2 | $2.58M | Sell |
157,534
-1,640
| -1% | -$27.2K | ﹤0.01% | 1634 |
|
|
2015
Q1 | $2.83M | Buy |
159,174
+4,305
| +3% | +$80K | ﹤0.01% | 1579 |
|
|
2014
Q4 | $2.94M | Buy |
+154,869
| New | +$2.62M | ﹤0.01% | 1591 |
|
|
2014
Q2 | – | Sell |
-10,167
| Closed | -$160K | – | 2244 |
|
|
2014
Q1 | $160K | Sell |
10,167
-208
| -2% | -$3.39K | ﹤0.01% | 2179 |
|
|
2013
Q4 | $178K | Sell |
10,375
-192
| -2% | -$2.96K | ﹤0.01% | 2178 |
|
|
2013
Q3 | $139K | Buy |
+10,567
| New | +$125K | ﹤0.01% | 2182 |
|
Other funds holding ANGO
DSCM
SFM
AC
SBH
BAM
Principal Financial Group's ANGO Position: Q3 2025 in Review
Principal Financial Group sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 119,214 shares — an estimated $1.18M sold.
Principal Financial Group first reported a position in ANGO in Q3 2013 and held it in 44 quarters. The position peaked at $8.3M in Q2 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.
- Principal Financial Group reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
- Principal Financial Group sold 119,214 AngioDynamics shares in Q3 2025, an estimated $1.18M.
- Principal Financial Group first reported a position in AngioDynamics in Q3 2013 and held it in 44 quarters.
- Principal Financial Group's AngioDynamics position peaked at $8.3M in Q2 2021.
- 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.
Based on Principal Financial Group's 13F filing for Q3 2025, filed 4 Nov 2025.